Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 1999, p. 1556-1563, Vol. 65, No. 4
Animal Health
Research,1 Pharma
Research,2 and Central
Research,
Received 1 July 1998/Accepted 28 January 1999
Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is
widely used in the treatment of serious infections in humans. Its degradation by basidiomycetous fungi was studied by monitoring 14CO2 production from [14C]CIP in
liquid cultures. Sixteen species inhabiting wood, soil, humus, or
animal dung produced up to 35% 14CO2 during 8 weeks of incubation. Despite some low rates of
14CO2 formation, all species tested had reduced
the antibacterial activity of CIP in supernatants to between 0 and 33%
after 13 weeks. Gloeophyllum striatum was used to identify
the metabolites formed from CIP. After 8 weeks, mycelia had produced 17 and 10% 14CO2 from C-4 and the piperazinyl
moiety, respectively, although more than half of CIP (applied at 10 ppm) had been transformed into metabolites already after 90 h. The
structures of 11 metabolites were elucidated by
high-performance liquid chromatography combined with electrospray
ionization mass spectrometry and 1H nuclear magnetic
resonance spectroscopy. They fell into four categories as follows: (i)
monohydroxylated congeners, (ii) dihydroxylated congeners, (iii) an
isatin-type compound, proving elimination of C-2, and (iv)
metabolites indicating both elimination and degradation of the
piperazinyl moiety. A metabolic scheme previously described for
enrofloxacin degradation could be confirmed and extended. A new type of
metabolite, 6-defluoro-6-hydroxy-deethylene-CIP, provided confirmatory
evidence for the proposed network of congeners. This may result from
sequential hydroxylation of CIP and its congeners by hydroxyl radicals.
Our findings reveal for the first time the widespread potential for CIP
degradation among basidiomycetes inhabiting various environments,
including agricultural soils and animal dung.
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Degradation of Ciprofloxacin by Basidiomycetes and Identification
of Metabolites Generated by the Brown Rot Fungus
Gloeophyllum striatum
*
Corresponding author. Mailing address: Bayer AG,
Building 6700, D-51368 Leverkusen, Germany. Phone: 49 2173 38 4882. Fax: 49 2173 38 3766. E-mail:
heinz-georg.wetzstein.hw{at}bayer-ag.de.
Applied and Environmental Microbiology, April 1999, p. 1556-1563, Vol. 65, No. 4
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»